Goldline Pharmaceutical
SME IPO ListedSubscribed: 597.40x
IPO Snapshot
IPO Type
SME
Exchange
NSE Emerge / BSE SME
Issue Size
₹12 crore
Price Band
41–43
Lot Size
3000 shares
Minimum Application
₹1,29,000
Open Date
2026-05-12
Close Date
2026-05-14
Allotment Date
2026-05-18
Listing Date
2026-05-19
Registrar
BIGSHARE SERVICES PRIVATE LIMITED
Important: IPO investments involve market risk. Verify details from the RHP, exchange, or registrar before applying.
Company Overview
Based on publicly available DRHP / RHP filings
Company
Goldline Pharmaceutical
Exchange
NSE Emerge / BSE SME
Registrar
BIGSHARE SERVICES PRIVATE LIMITED
Issue Size
₹12 crore
Expected Listing
2026-05-19
Note: Detailed financials, objects of the issue, and risk factors are available in the company's DRHP/RHP filed with SEBI. Always read the offer document before investing.
Data Sources
IPO details are aggregated from public filings and market data. Verify all information with primary sources before investing.
Positives
- Heavily oversubscribed at 597.40x
Risks
- IPO investments carry market risk
- Issue size: 12
- Registrar: BIGSHARE SERVICES PRIVATE LIMITED
- Expected listing: 2026-05-19
Apply for Goldline Pharmaceutical IPO
Open a free Demat account and apply via ASBA / UPI in minutes
Angel One
Smart Investing- Free Demat account
- AI-powered research
- Zero brokerage on delivery
Sponsored: IPO Champion may earn a referral commission when you open an account through these links. This does not affect our editorial content.
Found this useful?
Share Goldline Pharmaceutical IPO details with your network
Investment Disclaimer: The information on this page is for educational purposes only and does not constitute investment advice. IPO investments are subject to market risks. Please read all offer documents carefully before investing. Past performance is not indicative of future results.